Opinion

Most Recent

image: Opinion: On “The Impact Factor Fallacy”

Opinion: On “The Impact Factor Fallacy”

By , , and | March 21, 2017

Papers published in low-impact journals are not necessarily low-quality scientific contributions.

1 Comment

image: Opinion: After We March

Opinion: After We March

By | March 16, 2017

How to become—and stay—involved in science policy 

4 Comments

image: Opinion: Birds of a Feather?

Opinion: Birds of a Feather?

By | March 10, 2017

Taking into account the interaction of nuclear and mitochondrial genes in birds holds the promise of more objectively defining what constitutes a species.

4 Comments

image: Opinion: Welcome to SciComm

Opinion: Welcome to SciComm

By | March 9, 2017

New to science communication? Here’s how to get started.

0 Comments

image: Opinion: Canine Models for Alzheimer’s

Opinion: Canine Models for Alzheimer’s

By | March 1, 2017

For research on drugs to treat neurodegenerative diseases, dogs offer a better predictor of clinical outcomes. 

7 Comments

image: Opinion: Is a Clone Really Born at Age Zero?

Opinion: Is a Clone Really Born at Age Zero?

By | February 21, 2017

More lessons from Dolly the sheep

1 Comment

image: Opinion: Sometimes, Scientists Must March

Opinion: Sometimes, Scientists Must March

By , , and | February 13, 2017

Lessons learned from the “Death of Evidence” demonstration in Canada

9 Comments

image: Opinion: Should Scientists Engage in Activism?

Opinion: Should Scientists Engage in Activism?

By | February 7, 2017

Scientists who accept funding with the tacit agreement that they keep their mouths shut about the government are far more threatening to an independent academy than those who speak their minds.

13 Comments

image: Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

By | February 1, 2017

What can be done to lower development costs and drug prices?

4 Comments

image: Opinion: Preparing for Potential Disasters

Opinion: Preparing for Potential Disasters

By | January 25, 2017

How to increase the resiliency of biotechnology organizations in the face of emergency risks

0 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Effects of Neanderthal DNA on Modern Humans
  3. Flux and Uncertainty in the CRISPR Patent Landscape
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech